Related Experiment Video
Updated: Sep 14, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Efficacy and Safety of Adenotonsillectomy for Pediatric Obstructive Sleep Apnea Across Various Age Groups: A
Mohammed Halawani1,2,3, Arwa Alsharif4, Omar Ibrahim Alanazi5
1Pediatric ENT, King Abdullah Specialized Children's Hospital (KASCH), Riyadh 11426, Saudi Arabia.
Insights
Adenotonsillectomy (AT) is effective for pediatric obstructive sleep apnea (OSA), with optimal results seen in children aged 3-7 years. Younger children (<3) face higher complication risks, while older children show less improvement.
Area of Science:
- Pediatric Otolaryngology
- Sleep Medicine
- Surgical Outcomes Research
Background:
- Obstructive sleep apnea (OSA) is a common condition in children.
- Adenotonsillectomy (AT) is a primary surgical treatment for pediatric OSA.
- Optimal timing for AT in relation to age and outcomes requires further clarification.
Purpose of the Study:
- To evaluate the safety and efficacy of adenotonsillectomy (AT) for pediatric obstructive sleep apnea (OSA).
- To analyze surgical outcomes based on patient age, disease severity, and follow-up duration.
- To determine the optimal age range for performing AT in children with uncomplicated OSA.
Main Methods:
- Systematic literature search across four electronic databases.
- Inclusion of 71 studies (before-and-after, cohort, RCTs) with 9087 participants.
- Analysis of surgical results stratified by age, disease severity, and follow-up duration.
Main Results:
- Children aged 3-7 years showed greater improvements in OSA severity, hypoxemia, sleep quality, and cardiovascular function compared to older children.
- Cognitive and behavioral improvements were linked more to follow-up duration than surgical age.
- Surgical complication rates were significantly higher in children under 3 years old.
Conclusions:
- Adenotonsillectomy (AT) is most effective and safest for pediatric obstructive sleep apnea (OSA) between ages 3 and 7.
- This age range balances disease resolution with reduced surgical risk.
- High-quality randomized controlled trials are recommended to refine clinical guidelines for pediatric AT.
Abstract:
Objectives: To assess the safety and efficacy of adenotonsillectomy (AT) for treating uncomplicated pediatric obstructive sleep apnea (OSA) in children of different ages. Methods: A systematic search was conducted in four electronic databases, and 71 studies with a total of 9087 participants were included in the analysis. The studies were all before-and-after studies, cohort studies, and randomized controlled trials. Surgical results were analyzed according to age, disease severity, and follow-up duration. Results: Children younger than 7 years at the time of AT had a significantly greater decrease in disease severity, a greater decrease in hypoxemic burden, improved sleep quality, and improved cardiovascular function than children older than 7 years. Both cognitive and behavioral performance improved postoperatively, although these changes were more significantly associated with the duration of follow-up than with age at surgery. Notably, the rate of surgical complications was much greater in children under the age of 3. Conclusions: The current evidence indicates that AT is performed optimally between the ages of 3 and 7 years, offering the greatest chance of disease resolution and remission of associated conditions, balanced with a reduction in surgical risk. We highly recommend conducting high-quality randomized controlled trials to further inform the clinical guidelines for pediatric AT.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Tonsillitis II: Management
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

